About Circle Pharma
Circle Pharma is a private company based in South San Francisco, California. It has reported $177,557,504 raised in four offerings on Form D since September 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 28, 2024 | Jul 3, 2024amended Jan 10, 2025 | $92,444,167of $117.3M target | 14 | $6.6M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Jun 15, 2021 | Jun 29, 2021amended Mar 22, 2022 | $66,304,990fully sold | 20 | $3.3M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 16, 2020 | Mar 23, 2020 | $14,999,999of $45.0M target | 7 | $2.1M | Equity, OptionsRule 506(b) | Form D ↗ |
| Sep 6, 2016 | Sep 9, 2016 | $3,808,348of $6.0M target | 4 | $952K | Equity, DebtRule 506(b) | Form D ↗ |
| Total, four offerings | $177,557,504 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Circle Pharma's Form D filed Jan 10, 2025.
TS
SK
Stephen Kelsey
Director
DE
David Earp
Executive officer and director
MJ
Matthew Jacobson
Director
WM
Walter Moos
Director
PP
Paul Park
Executive officer
JE
James Evangelista
Director
JJ
John Josey
Director
Earlier filings also listed Elton Satusky (executive officer, last listed Mar 2022), Peter Svennilson (director, last listed Mar 2020), Cayla McEwen (executive officer, last listed Mar 2020), Scott Lokey (director, last listed Sep 2016) and Douglas Crawford (director, last listed Sep 2016).